•The Texas comptroller's office recommended Bristol Myers Squibb's application for state tax incentives for its planned $1 billion manufacturing plant.
•The European Commission authorized an expanded label for VENCLYXTO to include new combination therapies for previously untreated chronic lymphocytic leukemia patients.
•UnitedHealth's insurance unit announced it will eliminate prior approval requirements for about two-thirds of healthcare services for members under age 18.
•Kalshi filed a lawsuit against Minnesota following the Governor signing a law that criminalizes the operation and advertising of prediction market platforms.